Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates

Additional Metadata
Keywords	drug-eluting stent(s), dualantiplatelet therapy, high bleeding risk, high thrombotic risk, zotarolimus-eluting stent(s)
Persistent URL	doi.org/10.1016/j.jacc.2014.11.053, hdl.handle.net/1765/85158
Journal	Journal of the American College of Cardiology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Valgimigli, M., Patialiakas, A., Thury, A., McFadden, E., Colangelo, S., Campo, G., … Briguori, C. (2015). Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. Journal of the American College of Cardiology, 65(8), 805–815. doi:10.1016/j.jacc.2014.11.053

Publication